Global vaccine market report 2022 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Global vaccine market report 2022 PDF full book. Access full book title Global vaccine market report 2022 by World Health Organization. Download full books in PDF and EPUB format.
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240062726
Category : Medical
Languages : en
Pages : 60
Get Book Here
Book Description
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240062726
Category : Medical
Languages : en
Pages : 60
Get Book Here
Book Description
Author: Ruchir Agarwal
Publisher: International Monetary Fund
ISBN: 1513577603
Category : Business & Economics
Languages : en
Pages : 54
Get Book Here
Book Description
Urgent steps are needed to arrest the rising human toll and economic strain from the COVID-19 pandemic that are exacerbating already-diverging recoveries. Pandemic policy is also economic policy as there is no durable end to the economic crisis without an end to the health crisis. Building on existing initiatives, this paper proposes pragmatic actions at the national and multilateral level to expeditiously defeat the pandemic. The proposal targets: (1) vaccinating at least 40 percent of the population in all countries by the end of 2021 and at least 60 percent by the first half of 2022, (2) tracking and insuring against downside risks, and (3) ensuring widespread testing and tracing, maintaining adequate stocks of therapeutics, and enforcing public health measures in places where vaccine coverage is low. The benefits of such measures at about $9 trillion far outweigh the costs which are estimated to be around $50 billion—of which $35 billion should be paid by grants from donors and the residual by national governments potentially with the support of concessional financing from bilateral and multilateral agencies. The grant funding gap identified by the Access to COVID-19 Tools (ACT) Accelerator amounts to about $22 billion, which the G20 recognizes as important to address. This leaves an estimated $13 billion in additional grant contributions needed to finance our proposal. Importantly, the strategy requires global cooperation to secure upfront financing, upfront vaccine donations, and at-risk investment to insure against downside risks for the world.
Author: Gregory Zuckerman
Publisher: Penguin
ISBN: 0593420403
Category : Business & Economics
Languages : en
Pages : 384
Get Book Here
Book Description
"An inspiring and informative page-turner." –Walter Isaacson Longlisted for the FT/McKinsey Business Book of the Year Award The authoritative account of the race to produce the vaccines that are saving us all, from the #1 New York Times bestselling author of The Man Who Solved the Market Few were ready when a mysterious respiratory illness emerged in Wuhan, China in January 2020. Politicians, government officials, business leaders, and public-health professionals were unprepared for the most devastating pandemic in a century. Many of the world’s biggest drug and vaccine makers were slow to react or couldn’t muster an effective response. It was up to a small group of unlikely and untested scientists and executives to save civilization. A French businessman dismissed by many as a fabulist. A Turkish immigrant with little virus experience. A quirky Midwesterner obsessed with insect cells. A Boston scientist employing questionable techniques. A British scientist despised by his peers. Far from the limelight, each had spent years developing innovative vaccine approaches. Their work was met with skepticism and scorn. By 2020, these individuals had little proof of progress. Yet they and their colleagues wanted to be the ones to stop the virus holding the world hostage. They scrambled to turn their life’s work into life-saving vaccines in a matter of months, each gunning to make the big breakthrough—and to beat each other for the glory that a vaccine guaranteed. A #1 New York Times bestselling author and award-winning Wall Street Journal investigative journalist lauded for his “bravura storytelling” (Gary Shteyngart) and “first-rate” reporting (The New York Times), Zuckerman takes us inside the top-secret laboratories, corporate clashes, and high-stakes government negotiations that led to effective shots. Deeply reported and endlessly gripping, this is a dazzling, blow-by-blow chronicle of the most consequential scientific breakthrough of our time. It’s a story of courage, genius, and heroism. It’s also a tale of heated rivalries, unbridled ambitions, crippling insecurities, and unexpected drama. A Shot to Save the World is the story of how science saved the world.
Author: American Academy of Pediatrics
Publisher:
ISBN: 9781610021814
Category : Immunity
Languages : en
Pages : 0
Get Book Here
Book Description
This collection of policies and articles addresses vaccine schedules, the safety of vaccines, and methods for addressing vaccine hesitancy. Vaccine delivery is a substantive portion of pediatric practice, and addressing vaccine hesitancy is time-consuming. This collection of articles will assist providers by providing vaccine information and policy statements in a single, easily accessible platform. We hope to support vaccine confidence and increase immunization of infants and children.
Author: Christopher Dye
Publisher: Oxford University Press
ISBN: 0198887159
Category : Medical
Languages : en
Pages : 301
Get Book Here
Book Description
The proverbial benefits of prevention over cure are self-evidentDland yet we are reluctant to invest in protecting and improving our health. Resolution of this age-old dilemma begins with a timeless truth: the benefits of good health come at a cost; prevention is not better than cure at any price. Protecting health should be appealing when a high-risk, high-value hazard can be averted rapidly, with certainty, and at relatively low cost. Similar reasoning applies when the goal is to make health gains, not merely to avoid health losses. Health choices are rational, based on values that are personal. Investing in Health and Wellbeing: When Prevention Is Better than Cure, Second Edition provides a framework to promote and protect health as an asset, illustrating the principles with practical examples. Application of these ideas helps to explain why prevention is a low priority for health services, why the world was not ready for the COVID-19 pandemic, why deadly infections like tuberculosis are neglected, why cigarette smoking is still commonplace, why billions still do not have access to safe sanitation, and why the response to climate change has been so slow. Much more money and effort are invested in health promotion and disease prevention today than is commonly thought, but the enormous avoidable burden of illness is reason to look for ways of investing still more. Previously published as The Great Health Dilemma (ISBN: 9780198853824) in 2021, this second, updated edition makes prevention part of a broader vision for better health. This is an open access title available under the terms of a CC BY-NC-ND 4.0 International licence. It is free to read on the Oxford Academic platform and offered as a free PDF download from OUP and selected open access locations.
Author:
Publisher: BoD – Books on Demand
ISBN: 1837686289
Category : Medical
Languages : en
Pages : 280
Get Book Here
Book Description
New Topics in Vaccine Development explores the latest advancements and future directions in vaccinology across 11 chapters, each addressing a different and specific facet. This book is an essential resource for clinicians, researchers, scientists, and students in immunology aiming to deepen their understanding of this crucial field.
Author: OECD
Publisher: OECD Publishing
ISBN: 9264431683
Category :
Languages : en
Pages : 145
Get Book Here
Book Description
This report offers insights into the risks and vulnerabilities of the supply chains of medicines and medical devices. Policy options to anticipate and mitigate risks of shortages of medicines and medical devices, both routinely and in the context of severe crises, are analysed. Most importantly, the report shows that strengthening the long-term resilience of medical supply chains requires collaborative approaches that balance measures best undertaken by the private sector with those more appropriately managed by governments or supranationally.
Author: Da LIU（柳達）
Publisher: 商務印書館（新加坡）有限公司
ISBN: 9620775716
Category : Political Science
Languages : en
Pages : 408
Get Book Here
Book Description
This book systematically expounds the history of the global pharmaceutical industry in the past 50 years, adopts the philosophical theory of "paradigm" and "paradigm shift", analyzes the current investment hot areas, and predicts potential “life sciences unicorns”. Written by many industry opinion leaders, this book is a rare professional work that combines practice with theory, combines Chinese characteristics with a global perspective, and combines business with science. With the purpose of popularizing knowledge and education, this book uses a large number of cases, introductions, recommended books and report catalogs, so that readers can learn and think systematically and comprehensively.
Author: Tim Schwab
Publisher: Metropolitan Books
ISBN: 1250850088
Category : Social Science
Languages : en
Pages : 276
Get Book Here
Book Description
New York Times Editors' Choice A powerful investigation of Bill Gates and the Gates Foundation, showing how he uses philanthropy to exercise enormous political power without accountability Through his vaunted philanthropy, Bill Gates transformed himself from a tech villain into one of the most admired people on the planet. Even as divorce proceedings and allegations of misconduct have recently tarnished his public image, the beneficence of the Gates Foundation, celebrated for spending billions to save lives around the globe, is taken as a given. But as Tim Schwab shows in this fearless investigation, Gates is still exactly who he was at Microsoft: a bully and monopolist, convinced of his own righteousness and intent on imposing his ideas, his solutions, and his leadership on everyone else. At the core, he is not a selfless philanthropist but a power broker, a clever engineer who has innovated a way to turn extreme wealth into immense political influence—and who has made us believe we should applaud his acquisition of power, not challenge it. Piercing the blinding halo that has for too long shielded the world’s most powerful (and most secretive) charitable organization from public scrutiny, The Bill Gates Problem shows how Gates’s billions have purchased a stunning level of control over public policy, private markets, scientific research, and the news media. Whether he is pushing new educational standards in America, health reforms in India, global vaccine policy during the pandemic, or Western industrialized agriculture throughout Africa, Gates’s heady social experimentation has shown itself to be not only undemocratic, but also ineffective. In many places, Bill Gates is hurting the very people he intends to help. No less than dark-money campaign contributions or big-business political lobbying, Bill Gates’s philanthropic empire needs to be seen as a problem of money in politics. It is a dangerous model of unconstrained power that threatens democracy and demands our attention.
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240092447
Category : Business & Economics
Languages : en
Pages : 73
Get Book Here
Book Description
The Local Production and Assistance (LPA) Unit in the Regulation and Prequalification Department (RPQ), Access to Medicines and Health Products Division (MHP), WHO, supports Member States, particularly low- and middle-income countries (LMICs), to strengthen sustainable local production and technology transfer to improve timely, equitable access to quality, safe and effective essential medical products. The LPA Unit provides assistance and support to Member States with an ecosystem-wide and holistic approach, such as fostering global coordination and partnerships, conducting ecosystem assessments for sustainable, quality local production, developing and implementing strategies/roadmaps, providing comprehensive capacity building and technical assistance, including for WHO Prequalification (PQ)/Emergency Use Listing (EUL), facilitating technology transfer (TT) and developing global resources on local production and TT. A landmark resolution WHA74.6 on strengthening local production of medicines and other health technologies to improve access was adopted in the Seventy-fourth World Health Assembly, signalling globally the important role local production plays in improving access and strengthening health security. Within this mandate, the LPA Unit, developed a series of case studies on the ecosystem for local production of pharmaceuticals, vaccines and biologicals, with a focus on country context in the low- and middle-income countries. These case studies add to the existing repository of resources on strengthening local production and technology transfer of health products for countries to leverage upon when countries embark in these areas. The countries in this series are Bangladesh, Kenya, Nigeria, Pakistan, Senegal and Tunisia. From June to September 2022, a series of interviews and consultative meetings, including a review of available literature, policies and other documents, and administration of a questionnaire, were performed. This case study is intended to report the collated information in areas such as available policies, initiatives, financing, regulatory system, patent protection system, research and development work, markets and capacity and preparedness to uptake local production of quality-assured pharmaceuticals, vaccines (including mRNA vaccines) and biologicals. Stakeholder perspectives on the expectations and needs of countries were also collected and included in the case studies, along with proposed recommendations, for the reader to see various viewpoints towards strengthening sustainable local production and achieving universal health coverage and the Sustainable Development Goals.
